Study RIN-PF-302 is designed to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis.
- Investigator
- Ibrahim Faruqi
- Status
- Accepting Candidates
- Ages
- 40 Years - N/A
- Sexes
- All
My locations
Active clinical trials
Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.
- Investigator
- Ibrahim Faruqi
- Status
- Accepting Candidates
- Ages
- 40 Years - N/A
- Sexes
- All
Search our accepted insurances list
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.